Zobrazeno 61 - 70
of 140
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
Amer H. Zureikat, Herbert J. Zeh, Amr I. Al Abbas, Ahmad Hamad, Caroline J. Reiser, Melissa E. Hogg, Mazen S. Zenati
Publikováno v:
Journal of the American College of Surgeons. 227:S248-S249
Autor:
David L. Bartlett, Amer H. Zureikat, A. James Moser, Murtaza Shakir, Herbert J. Zeh, Allan Tsung, Brian A. Boone, Patricio M. Polanco, Melissa E. Hogg, Haroon A. Choudry, Mazen S. Zenati
Publikováno v:
HPB. 17(7):580-586
BackgroundRobotic distal pancreatectomy (RDP) is performed increasingly, but knowledge of the number of cases required to attain procedural proficiency is lacking. The aim of this study was to identify the learning curve associated with RDP at a high
Autor:
Herbert J. Zeh, Amer H. Zureikat, Trang Nguyen, Melissa E. Hogg, Jennifer Steve, Brian A. Boone, Mazen S. Zenati, David L. Bartlett
Publikováno v:
HPB. 17:594-599
BackgroundHepatic arterial anomalies (HAAs) are not infrequently encountered during pancreatic resections. In view of the current emergence of the robotic platform as a safe alternative to open surgery in experienced centres, this study sought to det
Autor:
Jennifer Chennat, Kenneth K. Lee, Andres Gelrud, Amber K. Clifford, Amer H. Zureikat, Herbert J. Zeh, Mazen S. Zenati, Mohammad Khreiss, Adam Slivka, Melissa E. Hogg, Georgios I. Papachristou
Publikováno v:
Journal of Gastrointestinal Surgery. 19:1441-1448
Walled-off pancreatic necrosis (WON) is a sequela of acute necrotizing pancreatitis in 15–40 % of cases. We sought to compare the outcomes of minimally invasive surgical and endoscopic cyst gastrostomy (CG) and necrosectomy for the management for s
Autor:
Nathan Bahary, Jennifer Steve, Herbert J. Zeh, David L. Bartlett, Amer H. Zureikat, Brian A. Boone, Melissa E. Hogg, Mazen S. Zenati, Aatur D. Singhi
Publikováno v:
Annals of Surgical Oncology. 21:4351-4358
Baseline carbohydrate antigen 19-9 (CA 19-9) is a useful prognostic marker in pancreatic ductal adenocarcinoma (PDA); however, data on the significance of a change in CA 19-9 following neoadjuvant therapy are lacking.All patients receiving neoadjuvan
Autor:
Kenneth K. Lee, Andrew Dopsovic, Charles M. Vollmer, Mazen S. Zenati, Herbert J. Zeh, Amer H. Zureikat, Melissa E. Hogg, Stacy J. Kowalsky, Eric G. Schaefer, Mashaal Dhir
Publikováno v:
Surgery. 163(4)
Various strategies to decrease postoperative pancreatic fistula after a distal pancreatectomy have proved unsuccessful. Because narcotics can cause spasm of the sphincter of Oddi and thereby increase pressure within the pancreatic duct stump, we hypo
Autor:
Ahmad Hamad, Amer H. Zureikat, Nathan Bahary, Mazen S. Zenati, Jennifer Steve, Kenneth K. Lee, Irene Epelboym, Melissa E. Hogg, Herbert J. Zeh
Publikováno v:
Annals of surgical oncology. 24(9)
Receipt of 6 cycles of adjuvant chemotherapy (AC) is standard of care in pancreatic cancer (PC). Neoadjuvant chemotherapy (NAC) is increasingly utilized; however, optimal number of cycles needed alone or in combination with AC remains unknown. We sou
Autor:
Kenneth K. Lee, Melissa E. Hogg, Amer H. Zureikat, Herbert J. Zeh, Mazen S. Zenati, Stacy J. Kowalsky, Jennifer Steve
Publikováno v:
The Journal of surgical research. 221
Background Ketorolac (Toradol), a commonly used nonselective nonsteroidal anti-inflammatory drug (NSAID) in the postoperative period, has been associated with increased risk of anastomotic leak after colon resection. The effect of postoperative NSAID
Autor:
Herbert J. Zeh, Melissa E. Hogg, Yong Chen, Vernissia Tam, Mazen S. Zenati, Stephanie Novak, Amer H. Zureikat
Publikováno v:
Journal of surgical education. 74(6)
Obtaining the proficiency on the robotic platform necessary to safely perform a robotic pancreatoduodenectomy is particularly challenging. We hypothesize that by instituting a proficiency-based robotic training curriculum we can enhance novice surgeo
Autor:
Amer H. Zureikat, Mazen S. Zenati, Patrick R. Varley, Stephanie Novak, Lee M. Ocuin, Melissa E. Hogg, Sharon Winters, Jennifer L. Miller-Ocuin, Herbert J. Zeh
Publikováno v:
Annals of surgical oncology. 24(8)
National Cancer Database analysis showed 70% of patients with stage I pancreatic adenocarcinoma (PDA) did not have surgery. We sought to analyze adherence to expected treatment (ET) by stage for PDA and identify factors that led to no treatment (NT)